Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic.

MLA

Fresse, Audrey, et al. “Adverse Drug Reaction Profile of Third-Generation Smallpox Vaccines Used in France during the 2022 Monkeypox Epidemic.” AIDS (London, England), vol. 38, no. 5, Apr. 2024, pp. 768–71. EBSCOhost, https://doi.org/10.1097/QAD.0000000000003838.

APA

Fresse, A., Massy, N., Fournier, D., Pinel, S., Beurrier, M., Antoine, M.-L., Petitpain, N., & Gillet, P. (2024). Adverse drug reaction profile of third-generation smallpox vaccines used in France during the 2022 monkeypox epidemic. AIDS (London, England), 38(5), 768–771. https://doi.org/10.1097/QAD.0000000000003838

Chicago

Fresse, Audrey, Nathalie Massy, Dorine Fournier, Sylvine Pinel, Mathilde Beurrier, Marie-Lauren Antoine, Nadine Petitpain, and Pierre Gillet. 2024. “Adverse Drug Reaction Profile of Third-Generation Smallpox Vaccines Used in France during the 2022 Monkeypox Epidemic.” AIDS (London, England) 38 (5): 768–71. doi:10.1097/QAD.0000000000003838.